231 related articles for article (PubMed ID: 18325077)
1. A high-affinity monoclonal anti-IgE antibody for depletion of IgE and IgE-bearing cells.
Laffer S; Lupinek C; Rauter I; Kneidinger M; Drescher A; Jordan JH; Krauth MT; Valent P; Kricek F; Spitzauer S; Englund H; Valenta R
Allergy; 2008 Jun; 63(6):695-702. PubMed ID: 18325077
[TBL] [Abstract][Full Text] [Related]
2. An anti-IgE monoclonal antibody that binds to IgE on CD23 but not on high-affinity IgE.Fc receptors.
Shiung YY; Chiang CY; Chen JB; Wu PC; Hung AF; Lu DC; Pan RL; Chang TW
Immunobiology; 2012 Jul; 217(7):676-83. PubMed ID: 22226669
[TBL] [Abstract][Full Text] [Related]
3. Sensitization of skin mast cells with IgE antibodies to Culicoides allergens occurs frequently in clinically healthy horses.
Wagner B; Miller WH; Erb HN; Lunn DP; Antczak DF
Vet Immunol Immunopathol; 2009 Nov; 132(1):53-61. PubMed ID: 19836083
[TBL] [Abstract][Full Text] [Related]
4. Isotypic analysis of grass pollen-specific antibodies in human plasma. 4. Biological activity of allergen-specific and autoanti-IgE antibody fractions on basophil histamine release.
Batard T; Weyer A; Laroze A; Ickovic MR; David B; Peltre G; Basuyaux B
Clin Exp Allergy; 1996 Nov; 26(11):1308-15. PubMed ID: 8955580
[TBL] [Abstract][Full Text] [Related]
5. A bispecific antibody against human IgE and human FcgammaRII that inhibits antigen-induced histamine release by human mast cells and basophils.
Tam SW; Demissie S; Thomas D; Daëron M
Allergy; 2004 Jul; 59(7):772-80. PubMed ID: 15180766
[TBL] [Abstract][Full Text] [Related]
6. CD300a is expressed on human basophils and seems to inhibit IgE/FcεRI-dependent anaphylactic degranulation.
Sabato V; Verweij MM; Bridts CH; Levi-Schaffer F; Gibbs BF; De Clerck LS; Schiavino D; Ebo DG
Cytometry B Clin Cytom; 2012 May; 82(3):132-8. PubMed ID: 22173928
[TBL] [Abstract][Full Text] [Related]
7. An immunoglobulin E-reactive chimeric human immunoglobulin G1 anti-idiotype inhibits basophil degranulation through cross-linking of FcepsilonRI with FcgammaRIIb.
Wigginton SJ; Furtado PB; Armour KL; Clark MR; Robins A; Emara M; Ghaemmaghami AM; Sewell HF; Shakib F
Clin Exp Allergy; 2008 Feb; 38(2):313-9. PubMed ID: 18070161
[TBL] [Abstract][Full Text] [Related]
8. FcepsilonRI-alpha siRNA inhibits the antigen-induced activation of mast cells.
Safaralizadeh R; Soheili ZS; Deezagi A; Pourpak Z; Samiei S; Moin M
Iran J Allergy Asthma Immunol; 2009 Dec; 8(4):177-83. PubMed ID: 20404387
[TBL] [Abstract][Full Text] [Related]
9. IgE-dependent and IgE-independent stimulation of human basophils increases the presence of immature FcεRIα by reversing degradative pathways.
Zaidi AK; MacGlashan D
Int Arch Allergy Immunol; 2011; 154(1):15-24. PubMed ID: 20664273
[TBL] [Abstract][Full Text] [Related]
10. Omalizumab inhibits acceleration of FcεRI-mediated responsiveness of immature human mast cells by immunoglobulin E.
Okayama Y; Kashiwakura J; Sasaki-Sakamoto T; Matsumoto K; Hashimoto N; Ohmori K; Kawakami T; Saito H; Ra C
Ann Allergy Asthma Immunol; 2012 Mar; 108(3):188-94. PubMed ID: 22374203
[TBL] [Abstract][Full Text] [Related]
11. A human monoclonal IgE antibody that binds to MGL_1304, a major allergen in human sweat, without activation of mast cells and basophils.
Ishii K; Hiragun M; Hiragun T; Kan T; Kawaguchi T; Yanase Y; Tanaka A; Takahagi S; Hide M
Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):99-104. PubMed ID: 26541454
[TBL] [Abstract][Full Text] [Related]
12. The effect of intravenous administration of a chimeric anti-IgE antibody on serum IgE levels in atopic subjects: efficacy, safety, and pharmacokinetics.
Corne J; Djukanovic R; Thomas L; Warner J; Botta L; Grandordy B; Gygax D; Heusser C; Patalano F; Richardson W; Kilchherr E; Staehelin T; Davis F; Gordon W; Sun L; Liou R; Wang G; Chang TW; Holgate S
J Clin Invest; 1997 Mar; 99(5):879-87. PubMed ID: 9062345
[TBL] [Abstract][Full Text] [Related]
13. Mapping of conformational IgE epitopes with peptide-specific monoclonal antibodies reveals simultaneous binding of different IgE antibodies to a surface patch on the major birch pollen allergen, Bet v 1.
Gieras A; Cejka P; Blatt K; Focke-Tejkl M; Linhart B; Flicker S; Stoecklinger A; Marth K; Drescher A; Thalhamer J; Valent P; Majdic O; Valenta R
J Immunol; 2011 May; 186(9):5333-44. PubMed ID: 21451110
[TBL] [Abstract][Full Text] [Related]
14. Antibody to FcεRIα Suppresses Immunoglobulin E Binding to High-Affinity Receptor I in Allergic Inflammation.
Hong JY; Bae JH; Lee KE; Kim M; Kim MH; Kang HJ; Park EH; Yoo KS; Jeong SK; Kim KW; Kim KE; Sohn MH
Yonsei Med J; 2016 Nov; 57(6):1412-9. PubMed ID: 27593869
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of human cord blood-derived mast cell responses by anti-Fc epsilon RI mAb 15/1 versus anti-IgE Omalizumab.
Mirkina I; Schweighoffer T; Kricek F
Immunol Lett; 2007 Apr; 109(2):120-8. PubMed ID: 17368811
[TBL] [Abstract][Full Text] [Related]
16. Allergen-induced histamine release in rat mast cells transfected with the alpha subunits of Fc epsilon RI.
Lowe J; Jardieu P; VanGorp K; Fei DT
J Immunol Methods; 1995 Jul; 184(1):113-22. PubMed ID: 7622863
[TBL] [Abstract][Full Text] [Related]
17. Anti-IgE as a mast cell-stabilizing therapeutic agent.
Chang TW; Shiung YY
J Allergy Clin Immunol; 2006 Jun; 117(6):1203-12; quiz 1213. PubMed ID: 16750976
[TBL] [Abstract][Full Text] [Related]
18. A molecular model of type I allergy: identification and characterization of a nonanaphylactic anti-human IgE antibody fragment that blocks the IgE-FcepsilonRI interaction and reacts with receptor-bound IgE.
Laffer S; Hogbom E; Roux KH; Sperr WR; Valent P; Bankl HC; Vangelista L; Kricek F; Kraft D; Grönlund H; Valenta R
J Allergy Clin Immunol; 2001 Sep; 108(3):409-16. PubMed ID: 11544461
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of ongoing allergic reactions using a novel anti-IgE DARPin-Fc fusion protein.
Eggel A; Buschor P; Baumann MJ; Amstutz P; Stadler BM; Vogel M
Allergy; 2011 Jul; 66(7):961-8. PubMed ID: 21272035
[TBL] [Abstract][Full Text] [Related]
20. Treatment of chronic autoimmune urticaria with omalizumab.
Kaplan AP; Joseph K; Maykut RJ; Geba GP; Zeldin RK
J Allergy Clin Immunol; 2008 Sep; 122(3):569-73. PubMed ID: 18774392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
